Novo Nordisks data shows that patients with Type 2 diabetes are seeing their hemoglobin A1C levels drop to under 7
Further investigation is warranted to determine the optimal dosages and long-term effects of medications for T2DM and identify the variables contributing to heterogeneity through meta-regression analysis, mostly due to differences in study design, patient demographics, and treatment regimes
If youre early in the process, taking a free online health assessment can help organize the questions youll need answered before a formal visit
Tesoriere L, D'Arpa D, Butera D, et al
is the only United States company with FDA-approved products containing semaglutide, identified under the trade names Rybelsus, Ozempic and Wegovy